Concord Biotech IPO Subscription Status
Concord Biotech IPO was subscribed 24.87 times when bidding closed on 8 Aug 2023: QIB 67.67x, NII 16.99x, Retail 3.78x.
The Concord Biotech IPO has been subscribed 24.87x times overall. Retail investors have shown interest with bids for 3.78x the shares available. The Non-Institutional Investor (NII) category has been subscribed 16.99x. Within NII, Big HNI (B-HNI) subscribed 19.3x and Small HNI (S-HNI) subscribed 12.37x. Qualified Institutional Buyers (QIBs) have subscribed 67.67x. Data last updated on 10 Nov, 06:04 PM.
The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 04 Aug, 2023 and closes on 08 Aug, 2023. The shares are expected to list on stock exchanges on 18 Aug, 2023.
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| QIB | - of - - | 67.67x |
| NII | - of - - | 16.99x |
bHNI — bid amount above ₹10 Lakh |
- - | 19.3 |
sHNI — bid amount ₹2–10 Lakh |
- - | 12.37 |
| Retail | - of - - | 3.78x |
| Employee | - of - - | 24.48x |
| TOTAL | - - | 24.87x |
Concord Biotech IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
Subscription is above 1x. While a lottery is guaranteed, your probability of allotment is approximately 26.5% for a single lot.
Institutional Backing
Massive institutional interest with QIBs subscribing 67.67x. This often signals long-term confidence from professional funds.
Day-wise subscription history
End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
08 Aug 2023
Day 3 |
24.87x | ▼ | |
|
QIB67.67x
BHNI19.3x
SHNI12.37x
Retail3.78x
Employee24.48x
|
|||
|
07 Aug 2023
Day 2 |
2.72x | ▼ | |
|
QIB1.61x
BHNI5.12x
SHNI5.42x
Retail2.26x
Employee15.68x
|
|||
|
04 Aug 2023
Day 1 |
0.58x | ▼ | |
|
QIB0.01x
BHNI0.96x
SHNI1.11x
Retail0.72x
Employee5.73x
|
|||
Concord Biotech IPO dates
From the bidding window to listing. Today is 17 November.
- Open 04 Aug 2023
- Close 08 Aug 2023
- Allotment 11 Aug 2023
- Refund/credit 14 Aug 2023
- Listing 18 Aug 2023
Anchor investor allocation
Shares allotted to anchor investors the working day before the issue opened.
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Concord Biotech IPO?
As of IPO close date (08 Aug, 2023), the Concord Biotech IPO is subscribed 24.87x times. Retail category is 3.78x, and NII is 16.99x subscribed.
When is the allotment date for Concord Biotech IPO?
The allotment for Concord Biotech IPO is expected to be finalized on 11 August, 2023.
What is the GMP of Concord Biotech?
The Grey Market Premium (GMP) for Concord Biotech is currently ₹67.67, indicating a potential listing gain of 9%.
When will Concord Biotech IPO list on the stock market?
Concord Biotech is scheduled to list on BSE and NSE on 18 August, 2023.
What are the chances of getting allotment in Concord Biotech IPO?
The retail category is oversubscribed at 3.78x, meaning allotment is by lottery. Statistically, approximately 1 in 4 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 67.67x mean for Concord Biotech IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 67.67x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Concord Biotech IPO allotment status?
After the allotment date (11 Aug, 2023), you can check your Concord Biotech IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Concord Biotech IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.